DEVELOPMENT OF COGNITIVE IMPAIRMENTS IN DIABETIC PATIENTS AFTER PREVIOUS ISCHEMIC STROKE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Diabetes mellitus (DM) that has reached epidemic proportions in the past decade serves as one of the major risk factors of stroke, ischemic stroke in particular. The main cause of death in type 2 DM is vascular (including cerebrovascular) complications. Due to cognitive deficit occurring in DM, the patients are a dementia risk group. The use of Noojerone may slow down the progression of neuro-degenerative diseases and accelerate speech recovery.

Full Text

Restricted Access

References

  1. Дамулин И.В., Парфенов В.А., Скоромец А.А. и др. Нарушения кровообращения в головном и спинном мозге. В кн.: Болезни нервной системы. Т. 1. Под ред. Н.Н. Яхно. Рук-во для врачей. - М.: Медицина, 2005.
  2. Инсульт: диагностика, лечение и профилактика // Под ред. З.А. Суслиной, М.А. Пирадова / М.: МЕДпресс-информ, 2008.
  3. Фейгин В., Виберс Д., Браун Р. Инсульт. Клин. рук-во / М.: Бином. СПб: Диалект, 2005.
  4. Dhamoon M., Tai W., Boden-Albala B. et al. Risk of myocardial infarction or vascular death after first ischemic stroke // Stroke. - 2007; 38: 1752-8.
  5. Furie K., Kasner S., Adams R. et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline // Stroke. - 2011; 42: 227-76.
  6. Болезни нервной системы. Рук-во для врачей // Под ред. Н.Н. Яхно, Д.Р. Штульмана / М.: Медицина. - 2004; 1: 231-302.
  7. Rydén L. et al. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) // Eur. Heart J. - 2007; 28: 88-136.
  8. Bloomgarden Z. Cardiovascular disease in diabetes // Diabetes Care. - 2008; 31: 1260-6.
  9. Furie K., Kasner S., Adams R. et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. AHA/ASA Guideline // Stroke. - 2011; 42: 227-76.
  10. Censori B. et al. Dementiaafter first stroke // Stroke. - 1996; 27: 1205-10.
  11. Ford E. Prevalence of the metabolic syndrome defined by the diabetes federation among adults in the U.S. // Diabetes Care. -2005; 28: 2745-9.
  12. Awad N., Gagnon M., Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function // J. Clin. Exp. Neuropsychol. -2004; 26: 1044-80.
  13. Craft S. The Role of Metabolic Disordersin Alzheimer Diseaseand Vascular Dementia // Arch. Neurol. - 2009; 66: 300-5.
  14. Schrijvers E., Witteman J., Sijbrands E. et al. Insulin metabolism and the risk of Alzheimer disease. The Rotterdam Study // Neurology. - 2010; 75: 1982-7.
  15. Biessels G., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review // Lancet Neurol. - 2006; 5 (1): 64-74.
  16. Tatemichi T., Desmond D., Mayeux R. et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort // Neurology. - 1992; 42: 1185-93.
  17. Roman G.,Tatemichi T., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop // Neurology. - 1993; 43: 250-60.
  18. Sachdev P., Brodaty Н., Valenzuela M. еt al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients // Neurology. - 2004; 62: 912-9.
  19. Bowler J., Hachinski V. The concept of vascular cognitive impairment / In: Vascular cognitive impairment. T. Erkinjuntti, S. Gauthier (eds.). N.Y.: Martin Dunitz, 2002; р. 9-26.
  20. Censori B., Mariara O., Agostinis C. et al. Dementia after first stroke // Stroke. - 1996; 27: 1205-10.
  21. Desmond D., Moroney J., Paik M. et al. Frequency and clinical determinants of dementia after ischemic stroke // Neurology. - 2000; 56: 1124-31.
  22. Henon H., Durieu I., Guerouaou D. et al. Poststroke dementia: incidence and relationship to prestroke cognitive decline // Neurology. - 2001; 57: 1216-22.
  23. Leys D., Henon H., Mackowiak-Cordoliani M. et al. Poststroke dementia // Lancet Neurol. - 2005; 4 (11): 752-9.
  24. Lin J., Lin R., Tai C. Et al. Prediction poststroke dementia // Neurology. -2003; 61: 343-8.
  25. Rasquin S., Lodder J., Ponds R. et al. Cognitive functioning after stroke: a one-year follow-up study // Dement. Geriatr. Cogn. Disord. - 2004; 18: 138-44.
  26. Leys D., Pasquier F. Post-stroke dementia. VASCOG, San-Antonio. -2007; 21.
  27. Tang W., Chan S., Chiu H. et al. Frequency and determinants of poststroke dementia in Chinese // Stroke. - 2004; 35: 930-5.
  28. Idris I., Thomson G., Sharma J. Diabetes mellitus and stroke // Int. J. Clin. Pract. - 2006; 60 (1): 48-56.
  29. Stegmayr B., Asplund K. Diabetes as a risk factor for stroke. A population perspective // Diabetologia. - 1995; 38: 1061-8.
  30. Mankovsky B., Ziegler D. Stroke in patients with diabetes mellitus // Diabetes Met. Res. Rev. - 2004; 20: 268-87.
  31. Kalaria R. , Maestre G., Arizaga R. et al. Alzheimer’s disease and vascular dementia indeveloping countries: prevalence, management and riskfactors // Lancet Neurol. - 2008; 7: 812-26.
  32. Capes S., Hunt D., Malmberg K. et al. Stress hyperglycemia and prognosis of stroke on nondiabetic and diabetic patients // Stroke. - 2001; 32: 2426-32.
  33. Гусев Е.И., Скворцова В.И., Стаховская Л.В. Эпидемиология инсульта в России // Журн. неврол. и психиат. Инсульт. - 2003; 8: 4-9.
  34. Дамулин И.В. Сосудистая деменция // Неврол. журн. - 1999; 4: 4-11.
  35. Barba R., Martinez-Espinosa S., Rodriguez-Garcia E. et al. Poststroke dementia: clinical features and risk factors // Stroke. - 2000; 31: 1494-501.
  36. Скворцова В.И., Стаховская Л.В., Губский Л.В. и др. Рандомизированное двойное слепое плацебоконтролируемое исследование безопасности и эффективности церебролизина для лечения острого ишемического инсульта // Журн. неврол. и психиат. (Инсульт). - 2003; 11: 51-5.
  37. Скворцова В.И., Чазова И.Е., Стаховская Л.В. Вторичная профилактика инсульта / М.: ПАГРИ, 2002.
  38. Лурия А.Р. Травматическая афазия / М.: АМН СССР, 1947.
  39. Лукьянюк Е.В., Малюкова Н.Г., Шкловский В.М. Опыт применения акатинола мемантина в резидуальном периоде инсульта // Журн. неврол. и психиат. - 2010; 12: 28-33.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies